findmyKOL

Mary Hackney, MD

Basic profile

Virginia Commonwealth University

ORCIDNPI
RegionRichmond, VA · SoutheastSpecialtyMedical OncologyFocusOncology
Last active 2014findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH funding2012–2014Why? →

Mary Hackney is an Oncology physician affiliated with Virginia Commonwealth University. OpenAlex indexes 51 publications with 524 citations (h-index 13).

Overview

Scholarship

indexed output and impact (OpenAlex)
51publications

Distinct works indexed by OpenAlex, matched via ORCID.

524citations

Total citations across indexed works.

13h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 2012–2014

Federally funded research awards.

View funding

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    86%
    Aromatase Inhibitor67.2%
    Anastrozole51%Letrozole34%Exemestane16%
    Part D81 patients
    Kinase inhibitor11.1%
    Ibrance48%Verzenio28%Kisqali24%
    Part D<11 patients

    + 1 more class in this area

  • Nervous system

    4.8%
    Phenothiazine2.6%
    Prochlorperazine Maleate100%
    Part D18 patients
    Gabapentinoids2.2%
    Gabapentin100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    3.8%
    Serotonin-3 Receptor Antagonist3.8%
    Ondansetron Hcl100%
    Part D20 patients
Where care is delivered (Part B)42.6% facility · 57.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 20122014 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”